TNSN02023A1 - DERIVES DE PYRAZOLOPYRIMIDINE NOUVEAUX INHIBITEURS DE cGMP-PDE ET COMPOSITIONS LES CONTENANT. - Google Patents

DERIVES DE PYRAZOLOPYRIMIDINE NOUVEAUX INHIBITEURS DE cGMP-PDE ET COMPOSITIONS LES CONTENANT.

Info

Publication number
TNSN02023A1
TNSN02023A1 TNTNSN02023A TNSN02023A TNSN02023A1 TN SN02023 A1 TNSN02023 A1 TN SN02023A1 TN TNSN02023 A TNTNSN02023 A TN TNSN02023A TN SN02023 A TNSN02023 A TN SN02023A TN SN02023 A1 TNSN02023 A1 TN SN02023A1
Authority
TN
Tunisia
Prior art keywords
compositions containing
pde inhibitors
cgmp
pyrazolopyrimidine derivatives
novel cgmp
Prior art date
Application number
TNTNSN02023A
Other languages
English (en)
Inventor
Moira Norfor Allerton Charlotte
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of TNSN02023A1 publication Critical patent/TNSN02023A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

L'INVENTION CONCERNE UN COMPOSE DE FORMULE GENERALE I : DANS LAQUELLE R1 REPRESENTE H OU UN RADICAL ORGANIQUE. ELLE CONCERNE EGALEMENT UNE COMPOSITION LE CONTENANT. APPLICATION : UTILISATION DE CE COMPOSE OU DE CETTE COMPOSITION COMME INHIBITEUR DE cGMP-PDE, NOTAMMENT DE cGMP-PDE5, DANS LE TRAITEMENT CURATIF ET LE TRAITEMENT PROPHYLACTIQUE DE DIVERS ETATS PATHOLOGIQUES.
TNTNSN02023A 2001-03-09 2002-03-08 DERIVES DE PYRAZOLOPYRIMIDINE NOUVEAUX INHIBITEURS DE cGMP-PDE ET COMPOSITIONS LES CONTENANT. TNSN02023A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0105893.2A GB0105893D0 (en) 2001-03-09 2001-03-09 Pharmaceutically active compounds

Publications (1)

Publication Number Publication Date
TNSN02023A1 true TNSN02023A1 (fr) 2005-12-23

Family

ID=9910362

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN02023A TNSN02023A1 (fr) 2001-03-09 2002-03-08 DERIVES DE PYRAZOLOPYRIMIDINE NOUVEAUX INHIBITEURS DE cGMP-PDE ET COMPOSITIONS LES CONTENANT.

Country Status (8)

Country Link
AP (1) AP2002002462A0 (fr)
GB (1) GB0105893D0 (fr)
GT (1) GT200200044A (fr)
HN (1) HN2002000050A (fr)
PA (1) PA8541101A1 (fr)
PE (1) PE20021153A1 (fr)
TN (1) TNSN02023A1 (fr)
WO (1) WO2002072586A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
ES2341240T3 (es) 2002-12-13 2010-06-17 Warner-Lambert Company Llc Ligando alfa-2-delta para tratar los sintomas del tracto urinario inferior.
EP1653966A1 (fr) * 2003-07-16 2006-05-10 Pfizer Limited Traitement des dysfonctionnements sexuels
JP2009503020A (ja) 2005-08-03 2009-01-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 肥満症の治療におけるフリバンセリンの使用
EP1945214A1 (fr) 2005-10-29 2008-07-23 Boehringer Ingelheim International GmbH Derives de benzimidazolone utiles pour le traitement des troubles premenstruels et d'autres troubles sexuels chez la femme
EP2037927B1 (fr) 2006-06-30 2010-01-27 Boehringer Ingelheim International GmbH Flibansérine dans le traitement de l'incontinence urinaire et des maladies associées
BRPI0716439B8 (pt) 2006-08-14 2021-05-25 Boehringer Ingelheim Int sistemas de liberação farmacêutico compreendendo flibanserina, processo para preparação e uso dos mesmos
CN101505736A (zh) 2006-08-25 2009-08-12 贝林格尔.英格海姆国际有限公司 控制释放系统及其制造方法
UY31335A1 (es) 2007-09-12 2009-04-30 Tratamiento de sintomas vasomotores
CA2686480A1 (fr) 2008-12-15 2010-06-15 Boehringer Ingelheim International Gmbh Nouveaux sels

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0102543A3 (en) * 1998-04-20 2002-01-28 Pfizer Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction and medicaments containing them
GB9823101D0 (en) * 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
AP2002002455A0 (en) * 1999-10-11 2002-06-30 Pfizer 5-(2-substituted-5-heterocyclylsulphonylpyrid-3-yl)-dIhydropyrazolo[4,3-D] pyrimidin-7-ones as phosphodiesterase inhibitors.
CO5271697A1 (es) * 2000-01-12 2003-04-30 Pfizer Prod Inc Composiciones y procedimientos para el tratamiento de afecciones que responden a un aumento de testosterona

Also Published As

Publication number Publication date
PE20021153A1 (es) 2002-12-17
GT200200044A (es) 2002-12-02
GB0105893D0 (en) 2001-04-25
PA8541101A1 (es) 2003-11-12
HN2002000050A (es) 2002-09-13
WO2002072586A1 (fr) 2002-09-19
AP2002002462A0 (en) 2002-06-30

Similar Documents

Publication Publication Date Title
TNSN02008A1 (fr) Derives d'acides isophtalique nouveaux inhibiteurs de mmp, et compositions les contenant
TNSN02032A1 (fr) Derives de glutaramide a substituant n-phenpropylcyclopentyle nouveaux, et compositions les contenant.
NL300877I2 (nl) obeticholzuur
TNSN02012A1 (fr) Derives de pyrimidine nouveaux inhibiteurs de mmp, et compositions les contenant
TNSN00191A1 (fr) Composes nouveaux, compositions les contenant et leur utilisation dans le traitement d'une ischemie
TNSN02021A1 (fr) Derives de benzimidazole nouveaux, et compositions les contenant
TNSN02037A1 (fr) Sulfonylpyridazinones nouvelles inhibitrices d'aldose reductase et compositions les contenant
TNSN02011A1 (fr) Derives de pyrimidine bicycliques nouveaux, inhibiteurs de mmp, et compositions les contenant
EA200400006A1 (ru) Бензоилсульфонамиды и сульфонилбензамидины для применения в качестве противоопухолевых агентов
TNSN00092A1 (fr) Composes nouveaux antagonistes de npy, procede pour leur preparation et compositions pharmaceutiques les contenant
NO20041493L (no) Kjemiske forbindelser.
MA27771A1 (fr) 5,7-diaminopyrazolo[4,3-d]pyrimidines utiles dans le traitement de l'hypertension
TNSN01150A1 (fr) Pyrimidine-2,4,6- triones inhibitrices de metalloproteinases, et compositions les contenant.
DE60330150D1 (en) Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren
TNSN02022A1 (fr) Triazolopyridines anti-inflammatoires nouvelles, et compositions les contenant
ATE334666T1 (de) Neue fettsäureanaloge zur behandlung der fettleber
TNSN00198A1 (fr) COMPOSES NOUVEAUX INHIBITEURS DE cGMP PDE, PROCEDE POUR LEUR PREPARATION ET FORMULATIONS LES CONTENANT.
GB0127903D0 (en) Improvements relating to organic compounds
MA29160B1 (fr) Derives de triazole substitues, servant d'antagonistes d'ocytocine
CY1107747T1 (el) Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης
DK0939627T3 (da) Pentaflourbenzensulfonamider og analoger
ATE365740T1 (de) Substituierte pyrazolopyrimidine
ATE527261T1 (de) 7-aryl-3,9-diazabicycloä3.3.1ünon-6-en-derivate und ihre verwendung als renin-inhibitoren zur behandlung von bluthochdruck, herz-kreislauf- erkrankungen und nierenkrankheiten
TNSN02023A1 (fr) DERIVES DE PYRAZOLOPYRIMIDINE NOUVEAUX INHIBITEURS DE cGMP-PDE ET COMPOSITIONS LES CONTENANT.
MA27549A1 (fr) N-sulfonyl-4-methylene-amino-3-hydroxy-2-pyridones